Search

Search Constraints

You searched for: Author/Creator Onishi, Maika

Search Results

1. Brentuximab vedotin administered to platinum‐refractory, transplant‐naïve Hodgkin lymphoma patients can increase the proportion achieving FDG PET negative status. Issue 4 (18th September 2014)